Paul Schimmel, Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 27,823 shares at $150.00 ($4.2M) on 2018-03-13, disclosed to the SEC on 2018-03-14.
Open-market sale of $4.2M ALNY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ATYR | BUY | 2024-07-24 | $256K | — | Filing → |
| LIFE | BUY | 2023-05-11 | $450K | — | Filing → |
| LIFE | BUY | 2021-09-22 | $2.0M | — | Filing → |